Charles Cocuzza, CEO
Bridgeview Legal Funding Inc.
13951 N. Scottsdale Rd.
Scottsdale, AZ 85254
Fosamax Applications Now Being Accepted By Fundmysuit.com
Scottsdale, AZ – July 29, 2010-- http://Fundmysuit.com (Bridgeview Legal Funding Inc.) announced today that they are expanding their Pharmaceutical Drug list for pre-settlement funding for plaintiffs of Flosamax. This comes on the heels of a recent expansion into the highly publicized Avandia suits in which fundmysuit.com had already ramped up their operations. Flosamax has been linked to a serious and painfully side effect called Osteonecrosis of the jaw, also called “dead jaw”. As well, the Merck & Co. drug has been linked to the uncommon breaking of the Femur or thigh bone.
Fundmysuit.com CEO Charles Cocuzza commented on his firm’s willingness to begin funding cash advances to Flosomax suffers, “After adding the additional personel to take on Avandia suits, we are now adequately staffed to take on the substantial influx of Flosomax victims needing money. The adding of this drug to our funding portfolio continues to show the litigation funding industry that Fundmysuit.com is prepared to be a premiere player in funding “big pharma” cases. We look forward to assisting plaintiffs with the needed cash now for their cases, prior to their ultimate settlement.”
As reported by Reuters, Merck & Co. recently lost an $8mm Jury Verdict on one Fosamax case alone in NY. This opens the door to over 1200 other “class action” type suits to be potentially settled by Merck & Co. The plaintiff’s lawyer in that case, Tim O’Brien said, “Today’s verdict is just the first step, but it’s important because the jury found that Merck defectively designed the drug.”